机译:血浆高级糖化终末产物与2型糖尿病患者的心血管事件相关:一项病例队列研究,中位随访期为10年(EPIC-NL)
CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, the Netherlands,Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands;
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands;
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands;
CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, the Netherlands,Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands;
The National Institute for Public Health and the Environment, Bilthoven, the Netherlands;
The National Institute for Public Health and the Environment, Bilthoven, the Netherlands;
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands;
CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, the Netherlands,Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands;
CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, the Netherlands,Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands;
机译:晚期糖基化终产物的较高血浆水平与1型糖尿病的突发心血管疾病和全因死亡率有关:一项为期12年的随访研究。
机译:晚期糖化终产物(sRAGE)水平的更高血浆可溶性受体与1型糖尿病的事件性心血管疾病和全因死亡率相关:一项12年的随访研究
机译:先进的糖化末端产品,氧化产品和2型糖尿病患者的入射心血管事件
机译:基于MS的血浆蛋白单个糖化位点的定量作为潜在2型糖尿病生物标志物
机译:膳食晚期糖化末端产物(年龄)与I型糖尿病青年炎症和动脉僵硬
机译:2型糖尿病患者的高级糖基化终末产物氧化产物和心血管事件
机译:血浆高级糖化终末产物与2型糖尿病患者的心血管事件相关:一项病例队列研究,中位随访期为10年(EPIC-NL)